Background
==========

One of the most challenging problems for the otolaryngologist and the neurosurgeon is the treatment of large neoplasms involving the skull base and the inferolateral temporal bone. The intimate relationship of these tumors with the internal carotid artery and the dural venous sinuses might expose the patient to severe and life threatening intraoperative hemorrhage. The presence of the facial nerve in the middle of the operative field is responsible for technical difficulties in handling and achieving complete removal of the tumor and in controlling the bleeding without injuring the nerve. The intimate relation to the lower four cranial nerves might be responsible for postoperative handicapping functional problems as regarding the laryngeal competence.[@b1-cment-4-2011-021]

Congenital cholesteatoma (CC[@b1-cment-4-2011-021]) is thought to occur secondary to failure of normal involution of epidermoid formation within the middle ear cleft.[@b2-cment-4-2011-021]

Glomus jugulare tumors are benign lesions located in the jugular foramen and may extend into the middle ear, petrous apex and upper neck and may invade intradurally. Their surgical management is a challenge to both neurosurgeons and skull base surgeons. Despite the advancement in non-surgical techniques the only treatment with proven efficacy is radical surgical removal.[@b3-cment-4-2011-021]

Rosenwasser was the first to attempt radical surgical removal of the tumor.[@b4-cment-4-2011-021] Capps was the first author to perform anterior transposition of the facial nerve, occlusion of the sigmoid and ligature of the internal jugular vein in the neck in 1952.[@b5-cment-4-2011-021] Twenty six years later Fisch restored this approach giving a detailed description of what he called a type A approach for jugular foramen lesions and adding two more approaches (namely types B and C approaches) for more anteriorly situated lesions. The key elements in the Fisch type A approach, designed for glomus jugulare type C (according to Fisch classification) were anterior rerouting of the facial nerve and the permanent obliteration of the middle ear space.[@b6-cment-4-2011-021],[@b7-cment-4-2011-021] Despite the meticulous dissection, anterior facial nerve rerouting is frequently followed by transitory weakness postoperatively.[@b8-cment-4-2011-021]

The facial nerve is supplied through three main arterial systems (from the labyrinthine, the middle meningeal, and the stylomastoid arteries).[@b9-cment-4-2011-021]

Transposition requires skeletonization of the FN[@b2-cment-4-2011-021] in the fallopian canal, resection of attachments to the canal, and displacement of the FN in an anterior or posterior direction. Extrinsic and intrinsic blood supply are placed in jeopardy, especially with first genu rerouting. However, rerouting of the FN provides maximal jugular bulb and tumor exposure and facilitates tumor resection.[@b10-cment-4-2011-021]

During the last decades several article have been addressed to discuss glomus jugulare tumors, however few of them put into question the real need to anteriorly transpose the facial nerve as a prerequisite for proper surgical removal of such tumor.

The aim of this retrospective study is to present our experience in handling jugular foramen lesions (mainly glomus jugulare) without the need for anterior facial nerve transposition.

Methods
=======

This is a retrospective review of 36 patients, 23 females (63.9%) and 13 males (36.1%), 28 cases of glomus jugulare tumors classes C and D, 4 cases of glomus jugulare tumors Class B according to Fisch classification system, and 4 cases of congenital cholesteatoma of ME, surgically treated in Kasr ElEini University Hospital in Cairo, Egypt, from 1988 to 2008. Age range was 22 to 65 years (mean age 49 years).

**Preoperative assessment:** Included full clinical history taking and clinical examination of the patients as well as preoperative audiological evaluation by pure tone audiogram. Radiological evaluation included, contrast enhanced high resolution CT scan (HRCT[@b3-cment-4-2011-021]) and/or MRI with gadolinium for the skull base and the posterior cranial fossa. Routine preoperative 4 vessels angiography and embolization of the feeding external carotid vessels, was done 48 hours prior to the preplanned surgery.

**Staging:** The Fisch classification system was adopted to classify the glomus jugulare cases.[@b11-cment-4-2011-021]

Operative
=========

The four congenital Cholesteatoma cases were treated by retrofacial approach according to Jackson et al.[@b12-cment-4-2011-021]

The basic steps of the retrofacial approach (modified) in our practice were the following:

A regular post-auricular skin incision (the original Y-shaped parotidectomy-like incision was not adopted by our team seen not necessary) extending down to greater cornu of hyoid then the facial nerve was identified in the parotid. A cortical mastoidectomy was done followed by dissection of the facial recess that is then extended inferiorly till the meso and hypotympanum after cutting the chorda tympani. The sinus tympani was then opened. The drum and middle ear structures were removed except the stapes and its tendon. Then the postero-superior canal wall, mastoid tip and all bone lateral and anterior to jugular foramen and the bone covering the jugular bulb were all removed. The sternomastoid and digastric muscles were separated from mastoid tip. The cervical soft tissue component of the approach including vascular and neural components was not included in our approach since the cholesteatoma is non-vascular, non-adherent and readily resectable lesion macking this component of the approach unnecessary. The congenital cholesteatoma was then removed. The radical cavity was packed and the wound was closed in anatomical planes.

Three of the four glomus jugulare type B cases were treated by partial anterior rerouting technique according to Jackson.[@b13-cment-4-2011-021]

The basic steps of the partial anterior rerouting technique in our practice were:

Previous steps as in retrofacial approach are repeated in addition to:

The vertical mastoid segment of the facial nerve is liberated and partially rerouted anteriorly pivoted at the 2nd genu, giving larger space to handle the vertical infra-labyrinthine ICA and the jugular bulb with the related tumor. Also the cervical soft tissue component previously not included in the retrofacial approach was performed in this approach including identification of the great vessels and last 4 cranial nerves, and the ECA[@b4-cment-4-2011-021] and ascending pharyngeal artery were both ligated. The Eustachian tube (ET[@b5-cment-4-2011-021]) as well as the exteranal auditory canal (EAC[@b6-cment-4-2011-021]) are all handled the same way as in the classic Fisch A approach (ie, middle ear ossicles removal except the stapes, ET block and closure of the EAC as blind ended pouch). The wound is closed in anatomical planes.

One case of glomus jugulare class B (according to Fisch classification) was treated by a combined extended recess and hypotympanotomy together with mobilization of the facial nerve at the stylomastoid foramen. This approach is actually a mixture of the extended recess described by McCabe et al[@b14-cment-4-2011-021] and the post-aural hypotympanotomy described by Farrior[@b15-cment-4-2011-021] and is not very much different from the transmastoid infralabyrinthine approach described by Gjuric M and Bilic M.[@b16-cment-4-2011-021]

Its basic features are the same as in the previous approach with two differences:

The facial nerve was only freed at the stylomastoid foramen till below the chorda tympani but without mobilization of the whole vertical segment of the facial nerve. This was done through bone removal around the facial nerve till the level of chorda tympani only. The second difference is that the middle ear structures were not disturbed as well as the external auditory canal and the Eustachian tube.

The twenty eight glomus jugulare types C or D were treated by Fisch type A approach. The basic features of infratemporal fossa type A approach in our hands were identical to the literature.[@b6-cment-4-2011-021],[@b7-cment-4-2011-021] The main differences between our practice and the literature is that the sigmoid sinus is not ligated but packed from outside by surgicel and the IJV ligature in the neck is delayed as much as possible to avoid tumor congestion and bleeding.

**Postoperative care:** In the early post-operative period, all Fisch A cases were admitted to surgical ICU for 48 hours and all patients received intra and post-operative routine medical treatment in the form of IV 3rd generation cephalosporins, antacids, analgesics and steroids. Clinical post-operative care concentrated on the vagus nerve function, the healing process, monitoring of any wound infection or CSF[@b7-cment-4-2011-021] leak and the facial nerve function. A routine immediate tracheotomy operation was done and a NGT[@b8-cment-4-2011-021] was applied for all the 28 cases with Fisch A approach ie, C and D glomus jugulare cases. Then the vagus nerve function was evaluated after two days of full recovery. If the nerve function was found to be normal, the NGT and tracheotomy were eliminated. But if the vagal paralysis was symptomatic in the form of marked dysphonia and aspiration, the patient was provided with a tracheotomy tube with a speaking valve which was kept in place for three months to give a chance for spontaneous recovery and thereafter, if persistent symptoms, a type 1 thyroplasty medialization procedure was suggested. In case the paralysis was non-problematic for the patient, nothing further was done in relation to this aspect.

In relation to the facial nerve, in case of nerve sacrifice due to tumor infiltration, a greater auricular immediate cable graft was done as well as a gold implant of the upper eye lid later. In case post-operative complete paralysis with preserved anatomical integrity, gold implant was done for ocular protection and the patient was given a chance of 6 months for recovery. If no recovery at all, the patient was offered XII-VII anastomosis.

In general, patients were followed for 6 months to 2 years period, clinically for recurrence, hearing (post-operative PTA[@b9-cment-4-2011-021] was done), swallowing, dysphonia and facial nerve function. Radiologically, CT and/or MRI with gadolinium, were performed for patients to detect recurrence at three and six months from surgery. If found to be free, the patients were considered cured, but if recurrence occurred the patients were referred for radiotherapy (this is because all our recurrences/residues were due to irresectable ICA[@b10-cment-4-2011-021] infiltrations at the time of surgery).

Results
=======

Thirty two cases of glomus (28 C and D and 4 B cases) (according to Fisch and Oldering classification system) and four cases of congenital tympanic and hypotympanic cholesteatoma (see [Table 1](#t1-cment-4-2011-021){ref-type="table"}) were operated in Kasr El Eini University hospital (Cairo---Egypt) in the period from 1988 to 2008 with an overall complete resection rate of 80%. [Table 2](#t2-cment-4-2011-021){ref-type="table"} illustrates the detailed resection rate in relation to each pathology and disease stage. The presenting features for all cases of congenital cholesteatoma were conductive hearing loss and middle ear mass. While the presenting features for glomus were---in descending order of frequency: middle ear mass, hearing loss, pulsatile tinnitus, facial paralysis and finally vagal paralysis. [Table 1](#t1-cment-4-2011-021){ref-type="table"} illustrates the presenting features for glomus cases.

The outcome in the series was related to the type of pathology as well as the disease stage. Complete cure with complete pathology elimination without complications (100% success rate) could be achieved in the four cases of congenital cholesteatoma and the four cases with class B glomus ie, early disease (see [Tables 2](#t2-cment-4-2011-021){ref-type="table"}, [3](#t3-cment-4-2011-021){ref-type="table"} and [4](#t4-cment-4-2011-021){ref-type="table"}). However in advanced cases of glomus jugulare (28 patients) (C and D stages) complete pathology resection could be achieved in 21 of them (75%) due to tumor adherence to ICA and those seven patients were referred to radiotherapy for complementary treatment but this didn't prevent the disease progression (see [Table 2](#t2-cment-4-2011-021){ref-type="table"}). The operative complications were also related to this group of 28 patients, in the form of facial paralysis in 20 of them (55.6%) and symptomatic vagal paralysis in 18 of them (50%). (See [Tables 3](#t3-cment-4-2011-021){ref-type="table"} and [4](#t4-cment-4-2011-021){ref-type="table"} for the detailed rates and the management of the complication in each group). In the whole series there was one mortality in a young man in the 3rd decade of due to unexplained contra-lateral brain stem infarction. There was one case with persistent post-auricular sinus without evidence of infection and one 5th decade woman with auricular slough due to ischemia as a result of excessive extension of the pre-auricular limb of the incision (not adopted thereafter). For the post-operative morbidity other than the facial nerve, (see [Table 4](#t4-cment-4-2011-021){ref-type="table"}).

Discussion
==========

The most common tumor in the jugular foramen is the hypervascular glomus jugulare tumor followed by the schwannomas of the cranial nerves within the foramen. Less common tumors are the meningiomas, the hemangiopericytoma, the chondrosarcoma, the plasmacytoma, metastases and malignant tumors arising in adjacent anatomic structures ie, the nasopharynx, the parotid and the temporal bone.[@b17-cment-4-2011-021]

Glomus jugulare tumors present a formidable management problem because of their location and persistent invasive growth albeit usually slow and indolent. Surgical treatment of these tumors often causes considerable morbidity because of the extensive nature of skull-base procedures. With technical advancement in the surgical field, high speed drills and better microscopes, the focus of glomus jugulare tumor surgery has drifted away from the issue of resectability, virtually all of the glomus jugulare tumors are resectable (86%--94%).[@b18-cment-4-2011-021]--[@b20-cment-4-2011-021] Anand et al[@b21-cment-4-2011-021] were able to claim complete resection of the tumor in 100% of cases. Nowadays the emphasis is towards the functional outcome.

Irrespective of the approach, a central problem in extirpating lesions of the lateral skull base is the location of FN. Because of its long and irregular route through the temporal bone, any attempt at petrous resection often forces the surgeon either to sacrifice the FN or, more commonly, to reroute it.[@b22-cment-4-2011-021]

Historically, management of the FN required either anterior or posterior mobilization as described by Fisch[@b23-cment-4-2011-021] and House and Hitselberger,[@b24-cment-4-2011-021] respectively.

Anterior rerouting of the FN is a maneuver designed to enhance exposure of the jugular foramen and carotid canal during resection of cranial base tumors. At first it was described by Capps in 1952 however, despite mobilization, the tumor could not be removed completely. Because of postoperative facial weakness and spasm, Capps[@b5-cment-4-2011-021] expressed reluctance to repeat the procedure. The technique is used to preserve FN function and it has been widely reported and refined during the past 40 years. In 1964 Shapiro and Neues described microsurgical displacement of the FN supero-anteriorly after taking down the canal wall. After glomus tumor excision, the nerve was replaced, and temporary paralysis was resolved. Shapiro and Neues believed that this procedure was superior to the non-rerouting[@b25-cment-4-2011-021]. Selective approaches to preserve hearing were introduced, most notably by House and Farrior. During the latter part of the 1960s, McCabe et al[@b14-cment-4-2011-021] described the removal of glomus jugulare tumors with preservation of the osseus portion of the ear canal. Facial nerve translocation was not performed, which allowed the use of the facial recess and exposure of the hypotympanum for tumor extirpation. In 1967, Farrior[@b15-cment-4-2011-021] modified the endaural hypotympanotomy of Shambaugh,[@b26-cment-4-2011-021] stressing a postauricular hypotympanotomy. This approach was very effective in small glomus tumors with medial extension, but it was not effective in tumors that involved the anterior and medial surfaces of the ICA. In 1971 Hilding and Greenberg described anterior rerouting from the first genu for a patient who had only a temporary facial paralysis after tumor removal[@b27-cment-4-2011-021]. One of the first systematic descriptions of management of the FN according to tumor anatomy was done by Fisch and Pillsbury in 1979.[@b7-cment-4-2011-021] They described three management strategies. For extensive tumors of the temporal bone and skull base, standard rerouting was done, which entailed first genu rotation with displacement of the nerve into a bony groove in the epitympanum. For tumors limited to the infra-labyrinthine space and pyramid tip, rerouting was not considered necessary. However, if the tumor extended into the nerve, the infiltrated portion was resected and later replaced with a nerve graft, maintaining the anterior transposition.

Because of the unnecessary extensive FN manipulation risks of postoperative FN functional status, guidelines for selective use of rerouting techniques would be helpful. Transposition requires skeletonization of the FN in the fallopian canal, resection of the attachments to the canal, and displacement of the FN in an anterior or posterior direction. Extrinsic and intrinsic blood supply was placed in jeopardy, especially with first genu rerouting. However, rerouting of the FN provides maximal jugular bulb and tumor exposure so facilitates tumor resection.[@b10-cment-4-2011-021] According to Pensak and Jackler[@b22-cment-4-2011-021] when the surgeon approaches the jugular foramen, he must choose among three technical options: 1) Intact-canal-wall without FN rerouting (the so-called extended facial recess approach) 2) Canal-wall-down without FN rerouting, (the so-called Fallopian bridge technique or the retrofacial approach) and 3) Canal-wall-down with anterior FN rerouting (the classic Fisch A infratemporal fossa approach). The first option has the appeal of maintaining the structure and function of the ear canal and middle ear, but an intact-canal-wall procedure is not suitable for tumors with substantial anterior penetration. Use of a canal-wall-down procedure without FN rerouting is indicated when the ear canal wall is eroded or when tumor involvement of the middle ear is extensive. But unlike chronic ear surgery, the skull-base defect that created during a jugular foramen approach is too extensive for exteriorization. Furthermore, the highly skeletonized FN that bridges the surgical defect would be at risk of injury during routine cavity cleaning. Thus when the canal wall is taken down in jugular foramen surgery, the external auditory meatus must be sutured closed and the cavity is obliterated with either a free adipose tissue graft or a vascularized muscle graft. The third technical option, canal-wall-down with FN rerouting which was described by Fisch,[@b6-cment-4-2011-021] as the infratemporal fossa approach type A. This method is reserved for cases in which the tumor penetrates anteriorly with erosion of the carotid genu. In such cases, the added complexity of FN rerouting is justified by the need for unhindered exposure of the vasculature to avoid a potentially devastating carotid injury.

Von Doersten and Jackler[@b10-cment-4-2011-021] detailed more the handling of the facial nerve in relation to approaches to the jugular foramen. They described three levels in handling the facial nerve in relation to its anterior rerouting through 20 cadavers dissection. Those were canal wall up---second genu pivot point (CWU-2G[@b11-cment-4-2011-021]) (or the intact canal wall technique); canal wall down---second genu pivot point (CWD-2G[@b12-cment-4-2011-021]) (or the partial anterior transposition of the facial nerve); and canal wall down---first genu pivot point (CWD-1G[@b13-cment-4-2011-021]) (or the classic Fisch A approach). And they claimed that- through anatomic study- the gain of the distance between the vertical facial nerve at the stylomastoid foramen and the lateral edge of the jugular foramen (a distance that is required for proper tumor and vascular control without damage to the facial nerve) varies considerably with those three choices. With the first technique the mean distance is 4.2 mm, with the second technique the distance becomes 10 mm and it increased to 14 mm for the third technique. According to them, with the first technique the jugular bulb only is exposed, with second the bulb and 6 mm of the posterior aspect of the carotid genu is exposed and the third approach allows total exposure of the entire carotid genu. And hence proper approach selection tailored to the lesion allows proper lesion removal with preservation of the facial nerve function without the need for unnecessary retractions and mobilization. Gjuric and Bilic[@b16-cment-4-2011-021] introduced what they called the transmastoid infralabyrinthine approach (TM-IL[@b14-cment-4-2011-021]) for jugular paraganglimas, in which they preserved the structure and function of the external auditory canal and middle ear through an extended recess approach together with opening the retrofacial air cells and removing the bone anterior, posterior and medial to the facial nerve at the stylomastoid foramen and sepapration of the digastric muscle from the mastoid process. The facial nerve hence is liberated at the stylomastoid foramen which allows its mobilization at this level to expose the jugular bulb and by superior reflection of the tympanomeatal flap, they can expose the ICA up to the first genu. They claimed that through this approach surgical cure was achieved in (84%) of all the cases and in (73%) of the cases with IFT-A[@b15-cment-4-2011-021] approach, referring this to the fact that the IFT-A was selected to more aggressive disease form. Regarding their facial nerve outcome results, they got a postoperative House-Brackmann grade of I or II facial nerve function in 84% of TM-IL cases and in 56% of the IFT-A cases. They concluded that the TM-IL approach with individually tailored management of the facial nerve fulfills the long-term requirements of both keeping good postoperative facial function and obtaining adequate tumor resection.

Going through this enormous cumulative literature, we can summarize the levels of dealing with facial nerve in jugular foramen surgery into the following levels:

***First level***, no interference with the facial nerve, through the transmeatal approach. It is indicated for glomus tympanicum or limited hypotympanic cholesteatomas. It is either done through a post-auricular or an endaural approach. Three quarters tympanomeatal flap is created and the hypotymanum is exposed by cutting burr staying anterior to the posterior sulcus tympani and lesion is removed and the flap is repositioned.

***Second level*** is the extended facial recess approach for large glomus tympanicum lesions extending posteriorly beyond the posterior tympanic sulcus. Here after the cortical mastoidectomy is done the facial recess is opened and then extended inferiorly behind the meso and hypotympanum after excision of the chorda tympani staying between the vertical facial and the annulus. Then the lesion is removed and the anatomy and the function of the hearing conductive mechanism are not disturbed.

***Third level*** is the transmastoid infralabyrinthine approach described by Gjuric and Bilic,[@b16-cment-4-2011-021] in which they kept the integrity of the external auditory canal and the middle ear. They mobilized the facial nerve only at the stylomastoid foramen through an extended recess approach together with opening the retrofacial air cells and removing the bone that was anterior, posterior and medial to the facial nerve at the stylomastoid foramen and finally separation of the digastric muscle from the facial nerve. This exposes the jugular bulb and by superior reflection of the tympanomeatal flap and external auditory canal skin they can expose the ICA up to the first genu.

***Fourth level*** is the retrofacial approach (described in the hands of Pensak and Jackler above as the Fallopian bridge technique)[@b22-cment-4-2011-021] indicated for glomus jugulare C1 (according to Fisch classification), for infralabyrinthine congenital cholesteatoma and for drainage of petrous apex cholesterol granuloma provided the jugular bulb is not very high and the mastoid is cellular. Its basic features in this series in our hands in dealing with the four congenital cholesteatoma cases have been described above. Here the conductive hearing mechanism is disturbed both functionally and anatomically.

***Fifth level*** is the canal wall down with partial anterior rerouting of the facial nerve making the second genu of the facial nerve as the pivot point. According to Von Doersten and Jackler[@b10-cment-4-2011-021] this approach allows good control of the bulb and the posterior aspect of the genu of the ICA. However if the glomus jugulare lesion is beyond C1 we believe that this approach becomes contracted and risks poor vascular control of the ICA. The classic features of this approach have been also described above and again the conductive hearing mechanism is disturbed both functionally and anatomically.

***Sixth level*** is the canal wall down with total anterior rerouting of the facial nerve making the first genu of the facial nerve as the pivot point ie, classic Fisch A infratemporal fossa approach.[@b6-cment-4-2011-021] It is indicated for glomus jugulare cases with higher grading than C1 (according to Fisch). It carries the highest risk on facial nerve function due to facial nerve injury which may be complete or partial.

The conductive hearing mechanism is also disturbed both functionally and anatomically due to removal of middle ear contents except the stapes and the stapedius, in addition to the occlusion of the Eustachian tube and the EAC.

***In our series***, we performed the last four levels of facial nerve exposure:

1.  For congenital cholesteatomas of the hypotymanum and the middle ear we selected the retrofacial approach. We believe that unlike glomus, this approach is applied to the extremely vascular and adherent tumor to the surrounding structures (specially the ICA) which entails a wide approach for proper vascular control, congenital non-vascular cholesteatoma, non-adherent and readily resectable lesion. In such technique we did not attempt to mobilize the facial nerve at all and we did not ligate nor expose cervical blood vessels or nerves although we selected a vast approach that allowed us to properly remove the disease without facial nerve affection.

2.  For the glomus jugulare lesions class B (according to Fisch classification), we performed the partial anterior rerouting technique (the so-called canal wall down second genu pivot point) for three cases.

3.  For one case of glomus jugulare class B (according to Fisch classification) we performed the transmastoid infralabyrinthine approach. The vertical mastoid segment of the facial nerve was partially rerouted at the middle of the vertical segment below the chorda tympani (neither at the stylomastoid foramen nor totally till the second genu). The limited mobilization was found to be sufficient to expose the jugular bulb and the posterior aspect of the ICA and to liberate the tumor from it since the tumor in this particular case was not markedly adherent to the ICA. This is a little bit similar to the CWU 2nd G pivot described by Von Doersten and Jackler[@b10-cment-4-2011-021] and to the transmastoid infralabyrinthine approach described by Gjuric and Bilic[@b16-cment-4-2011-021] with some differences regarding the level of facial nerve mobilization. In such approach the middle ear structure and function are not disturbed and the outcome of the facial nerve was excellent.

4.  For larger glomus jugulare lesions (classes C or D according to Fisch), a classic Fisch infratemporal fossa type A approach[@b6-cment-4-2011-021] was selected (the so-called canal wall down first genu pivot point).

The facial nerve outcome was excellent at the first three approaches without facial nerve affection at all. But for the fourth approach (infratemporal fossa type A) immediate postoperative complete facial paralysis was present in 20 cases (55.6%) despite the anatomical integrity in 18 of them (50%) but only 8 patients (22.2%) partially recovered their facial nerve function without further intervention (see [Table 3](#t3-cment-4-2011-021){ref-type="table"}).

Unfortunately, and despite the numerous literature in handling glomus jugulare tumor over the last decades, comparing the results is very difficult due to the marked difference between patients' groups regarding the disease stage, the approaches adopted, the follow up period and the grading of the facial nerve outcome. The literature is full of more general guide lines than precise protocol of management. This requires further research with this respect to try to unify the management strategies, however the rarity of the condition as well as the interested otologists and skull base surgeons, makes this hard to achieve one center and possibly a multi-center study may be more convenient.

Conclusion
==========

We believe that total anterior rerouting of the facial nerve carries a high risk of facial paralysis postoperatively even if the anatomical integrity of the nerve was preserved possibly due to excessive handling and devascularization and may be fibrosis in the cavity. So it should be reserved for cases where the lesion extends beyond the vertical ICA to the horizontal ICA or the petrous apex and particularly in lesions known for their adherence and excessive vascularity. Otherwise, for less extensive lesions and less aggressive pathologies, less aggressive approaches in the previously described leveling could be adopted with less hazards.

We would like to express our deep gratitude to our colleagues -- both medical and paramedical -- in the departments of ENT, anaesthesia and ICU in Cairo university hospital for their friendly and positive cooperation throughout our practice period in the last 20 years. The gratitude is also extended to our radiology team whom without their help this patient care could not have been achieved. Finally we are extremely thankful to our patients for their cooperation, patience and understanding.

**Disclosure**

This manuscript has been read and approved by all authors. This paper is unique and is not under consideration by any other publication and has not been published elsewhere. The authors and peer reviewers of this paper report no conflicts of interest. The authors confirm that they have permission to reproduce any copyrighted material.

CC

:   congenital cholesteatoma

FN

:   facial nerve

HRCT

:   high resolution CT scan

ECA

:   external carotid artery

ET

:   eustachian tube

EAC

:   external auditory canal

CSF

:   cerebrospinal fluid

NGT

:   nasogastric tube

PTA

:   pure tone audiomatery

ICA

:   internal carotid artery

CWU-2G

:   canal wall up--second genu pivot point

CWD-2G

:   canal wall down--second genu pivot point

CWD-1G

:   canal wall down--first genu pivot point

TM-IL

:   transmastoid infralabyrinthine approach

IFT-A

:   infratemporal fossa approach type-A of Fisch.

![Preoperative CT of glomus jugulare.](cment-4-2011-021f1){#f1-cment-4-2011-021}

![Postperative CT of glomus jugulare.](cment-4-2011-021f2){#f2-cment-4-2011-021}

![Preoperative MRI of glomus jugulare.](cment-4-2011-021f3){#f3-cment-4-2011-021}

![Glomus tympanicum pre operative CT & MRI.](cment-4-2011-021f4){#f4-cment-4-2011-021}

![Congenital cholesteatoma preoperative CT axial and coronal.](cment-4-2011-021f5){#f5-cment-4-2011-021}

![Operative view of Fisch A approach.](cment-4-2011-021f6){#f6-cment-4-2011-021}

![Preoperative angiography of glomus jugulare.](cment-4-2011-021f7){#f7-cment-4-2011-021}

###### 

Illustrates the preoperative presentation and staging of the glomus patients.

  **Symptoms**               **Number and percentage of patients**
  -------------------------- ---------------------------------------
  Hearing loss               25 patients (69.4%)
  Pulsatile tinnitus         23 patients (63.9%)
  Middle ear mass            28 patients (77.8%)
  Dysphonia and dysphagia    7 patients (19.4%)
  Facial palsy               8 patients (22.2%)
  **Staging (for glomus)**   
  Class C and D              28 patients (87.5%)
  Class B                    4 patients (12.5%)

###### 

Illustrates the outcome of the operated patients in relation to the tumor resection.

  **Outcome**                               **Number and percent**
  ----------------------------------------- ---------------------------------------------------------------------
  **Tumor resection (for glomus)**          
  Complete                                  25[\*](#tfn1-cment-4-2011-021){ref-type="table-fn"} (78.1%)
  Partial (ICA infiltration-Radiotherapy)   7[\*](#tfn1-cment-4-2011-021){ref-type="table-fn"} (C or D) (19.4%)
  Complete for cong. Cholesteatoma.         4 patients (100%)

In relation to glomus cases

###### 

Illustrates the outcome of the operated patients in relation to the facial nerve outcome.

  **Facial nerve status post-op**         **Final facial outcome--clinical state and management**                                                      **Number--percent**
  --------------------------------------- ------------------------------------------------------------------------------------------------------------ ---------------------
  Anatomically & functionally intact      B cases (3 cases with partial ant. Rerouting and 1 case with combined extended recess and hypotympanotomy)   4 patients (11.1%)
  Cong. Cholest. (retrofacial approach)   4 patients (11.1%)                                                                                           
  **C & D cases (Fisch A)**                                                                                                                            
  Anatomically & functionally intact      No further management                                                                                        8 patients (22.2%)
  Anatomically & functionally affected    N. infiltration--sacrifice--great auricular graft and gold implant--partial recovery                         2 patients (5.6%)
  Anatomically intact but complete VII    Gold implant and 6 ms later:                                                                                 18 patients (50%)
  Partial recovery                        8 patients (22.2%)                                                                                           
  No recovery--refused XII-VII            7 patients (19.4%)                                                                                           
  No recovery--XII-VII                    3 patients (8.3%)                                                                                            

###### 

Illustrates the patients' outcome in relation to post-operative complications other than the facial nerve paralysis.

  **Outcome**                                               **Number and percent**
  --------------------------------------------------------- -----------------------------------------------------
  Vagal paralysis                                           
    4 cong. Cholesteatoma                                   Free 11.1%
    4 type B glomus                                         Free 11.1%
    28 types C & D                                          
    Postoperative tracheostomy & NGT                        All patients
    Persistent symptomatic palsy Thyroplasty (3 ms later)   18 patients (50%)
    Non-symptomatic palsy--nothing done                     4 patients (11.1%)
    Recovery (3 ms)                                         6 patients (16.7%)
  Death                                                     1 patient (2.8%)
  2 weeks later brain stem infarction                       
  Post-auricular fistula                                    1 patient (2.8%)--post-auricular resistant fistula
  Auricular slough                                          1 patient (2.8%) due to anterior incision extension
  CSF leak                                                  none
  Infection                                                 none
